Insider Trades - WINGER DENNIS L

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

WINGER DENNIS L: Declared Holdings
Company/Relationship	Reported	Shares	Ownership
Accuray Incorporated Director NasdaqGS:ARAY (historical quotes, profile, other insiders)	5-Mar-13	89,100	Direct
Nektar Therapeutics Director NasdaqGS:NKTR (historical quotes, profile, SEC, other insiders)	12-Dec-12 14-Sep-12	11,250 5,000 16,250	Direct Indirect Total
Vertex Pharmaceuticals Incorpor Director NasdaqGS:VRTX (historical quotes, profile, SEC, other insiders)	9-Mar-12	6,500	Direct

Insider & restricted shareholder transactions reported over the last two years
Date Shares Stock Transaction
5-Mar-13 20,000 ARAY Purchase at $4.30 per share.
(Cost of $86,000)
12-Dec-12 7,500 NKTR Option Exercise
30-Nov-12 19,108 ARAY Acquisition (Non Open Market) at $0 per share.
14-Sep-12 *5,000 NKTR Purchase at $9.18 per share.
(Cost of $45,900)
9-Mar-12 38,750 VRTX Disposition (Non Open Market) at $41.65 per share.
(Value of $1,613,937)
9-Mar-12 38,750 VRTX Acquisition (Non Open Market) at $34.05 - $34.24 per share.
(Value of about $1,323,000)
30-Nov-11 29,925 ARAY Acquisition (Non Open Market) at $0 per share.

* Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?

Insider & restricted shareholder transactions reported over the last two years
Date	Shares	Stock	Transaction
5-Mar-13	20,000	ARAY	Purchase at $4.30 per share. (Cost of $86,000)
12-Dec-12	7,500	NKTR	Option Exercise
30-Nov-12	19,108	ARAY	Acquisition (Non Open Market) at $0 per share.
14-Sep-12	*5,000	NKTR	Purchase at $9.18 per share. (Cost of $45,900)
9-Mar-12	38,750	VRTX	Disposition (Non Open Market) at $41.65 per share. (Value of $1,613,937)
9-Mar-12	38,750	VRTX	Acquisition (Non Open Market) at $34.05 - $34.24 per share. (Value of about $1,323,000)
30-Nov-11	29,925	ARAY	Acquisition (Non Open Market) at $0 per share.